JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2012, 61(1):40-43

Monitoring of effectiveness of some preventive measures against influenza

Lucia Masaryková2,*, Tomáš Baláži1, Magdaléna Fulmeková1,2, Ľubica Lehocká1
1 Department of Organization and Management of Pharmacy, Comenius University, Faculty of Pharmacy in Bratislava, Slovak Republic
2 Pharmacy of University, Comenius University, Faculty of Pharmacy in Bratislava, Slovak Republic

In our study we dealt with the frequently occurring influenza virus that infects humans regardless of age or sex. The flu is not of importance only in health problems but also in the economic ones, such as the treatment costs and patients' ability to work. We focused particularly on the most effective preventive measure against the virus, which is vaccination and the risk groups that are the most vulnerable ones to the virus. One of the objectives of this research was to identify the advantages and disadvantages of vaccination against influenza and available risks of vaccination within a group of 390 patients. We studied a group of 195 vaccinated patients and we tried to determine the effect of the vaccines used in these patients, and to compare this group with the same number of unvaccinated patients. The goal of the research was to identify the advantages and disadvantages of the vaccination against influenza, and the potential risks resulting from the vaccination. Based on our results, we found out that out of 195 vaccinated patients, only 4% returned to the doctor with the flu. Unvaccinated patients, however, visited the doctor four times more frequently, regardless of age. The resulting morbidity ratios clearly showed the importance, effectiveness and safety of the vaccination not only in high-risk groups, but also in people that are "out-of-danger", because the current flu virus spreads by droplet infection very quickly. Appropriate education and increased awareness among the population in Slovakia could improve the general attitude towards the vaccination against influenza and the vaccination rate (Slovakia 12%) could raise to a percentage comparable to that of the EU countries (France 30%, England 32%, the Netherlands 28% and Germany 26%).

Keywords: influenza; preventive measures; vaccination; effectiveness of vaccination

Received: August 25, 2011; Accepted: November 24, 2011; Published: January 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Masaryková L, Baláži T, Fulmeková M, Lehocká Ľ. Monitoring of effectiveness of some preventive measures against influenza. Čes. slov. farm. 2012;61(1-2):40-43.
Download citation

References

  1. Nichol K. L. Efficacy and effectiveness of influenza vaccination. Vaccine 2008; 26, 17-22. Go to original source... Go to PubMed...
  2. Marechal-Papillard S., Enouf V., Schnuriger A., Vabret A., Macheras E., Rameix-Welti M. A., Page B., Freymuth F., Werf S., Chenon-Garberg A., Chevallier B., Gaillard J. L., Gault, E. Monitoring epidemic viral respiratory infections using one-step real-time triplex RT-PCR targeting influenza A and B virusis and respiratory syncytial virusis. J Med Virol 2011; 83, 695-701. Go to original source... Go to PubMed...
  3. Krošlák M. Colds or flu? (in Slovak). Lekárske Listy 2007; 26, 17.
  4. Gajdziok J., Tajovská E., Bajerová M., Chalupová Z. Disease of the oral mucosa (in Czech). Prakt Lékáren 2010; 6, 26-28.
  5. Meier C. R., Napalkov P. N., Wegműller Y., Jefferson T., Jick H. Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis 2000; 19, 834-842. Go to original source... Go to PubMed...
  6. Neuzil K. M., Reed G.W., Mitchel E. F., Griffin M. R. Influenza associated morbidity and mortality in young and middle-aged women. J Am Med Assoc 1999; 281, 901-907. Go to original source... Go to PubMed...
  7. World Health Organization. Influenza. Fact sheet no. 211. Geneve Switzerland: WHO. Available at: http://www.who.int/mediacentre/factsheets/fs211/en/index.html; (accessed 30.10.09).
  8. Eurosurveillance - special issue on seasonal influenza vaccination, Stockholm: Sweden: ECDC. Available at: http://www.eurosurveillance.org/Public/PressReleases/ViewPressRelease.aspx?PressReleaseId@10; (accessed 30.10.09).
  9. EpiCentro, National Centre of Epidemiology, Surveillance and Health Promotion (Cnesps), Istituto Superiore di Sanita' (ISS). Health topics: influenza. Rome: Italy: ISS. Available at: http://www.epicentro.iss.it/problemi/influenza/influenza.asp; (accessed 30.10.09).
  10. La Torre G., Iarocci G., Cadeddu C., Boccia A. Influence of sociodemographic inequalities and chronic conditions on influenza vaccination coverage in Italy: Results from a survey in the general population. Public Health 2010; 124, 690-697. Go to original source... Go to PubMed...
  11. Blank P. R., Schwenkglencks M., Szucs, T. D. Disparities in influenza vaccination coverage rates by target group in five European countries: trends over seven consecutive seasons, Infection. 2009; 37, 390-400. Go to original source... Go to PubMed...
  12. Lorant V., Boland B., Humblet P., Deliége D. Equity in prevention and health care. J Epidemiol Community Health 2002; 56, 510-516. Go to original source... Go to PubMed...
  13. Mangtani P., Breeze E., Kovats S., Es N., Roberts J. A., Fletcher A. Inequalities in influenza vaccine uptake among people aged over 74 years in Britain. Prev Med 2005; 41, 545-553. Go to original source... Go to PubMed...
  14. Műller D., Saliou P., Szucs, T. D. Coverage rates of influenza vaccination in France: a population-based cross-sectional analysis of seasons 2001-2002 and 2002-2003. Med Mal Infect 2006; 36, 36-41.
  15. Damiani G., Federico B., Visca M., Agostini F., Ricciardi W. The impact of socioeconomic level on influenza vaccination among Italian adults and elderly: a cross-sectional study. Prev Med 2007; 45, 373-379. Go to original source... Go to PubMed...
  16. http://www.uvzsr.sk/docs/info/epida/The evaluation of the influenza season_2010_2011.pdf (in Slovak) (accessed 20. 5. 11)




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.